14.87 USD
-0.37 (-2.43%)
15 USD
+0.13 (+0.87%)
ChartMill assigns a Buy % Consensus number of 88% to LENZ. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 54.06. This target is 263.55% above the current price.
LENZ was analyzed by 13 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about LENZ.
In the previous month the buy percentage consensus was at a similar level.
LENZ was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-20 | Raymond James | Reiterate | Outperform -> Outperform |
| 2025-10-10 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-08-01 | Citigroup | Maintains | Buy -> Buy |
| 2025-08-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-07-31 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-07-31 | Citigroup | Maintains | Buy -> Buy |
| 2025-07-28 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-14 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-03-20 | Citigroup | Maintains | Buy -> Buy |
| 2024-11-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-27 | Raymond James | Initiate | Outperform |
| 2024-08-15 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-12 | HC Wainwright & Co. | Initiate | Buy |
| 2024-04-15 | Leerink Partners | Initiate | Outperform |
| 2024-04-15 | William Blair | Initiate | Outperform |
| 2024-04-10 | Citigroup | Initiate | Buy |
| 2024-03-27 | Piper Sandler | Initiate | Overweight |
LENZ THERAPEUTICS INC / LENZ FAQ
Can you provide the average price target for LENZ THERAPEUTICS INC stock?
13 analysts have analysed LENZ and the average price target is 54.06 USD. This implies a price increase of 263.55% is expected in the next year compared to the current price of 14.87.
How do analysts rate LENZ THERAPEUTICS INC (LENZ)?
The consensus rating for LENZ THERAPEUTICS INC (LENZ) is 87.6923 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed LENZ THERAPEUTICS INC (LENZ)?
The number of analysts covering LENZ THERAPEUTICS INC (LENZ) is 13.